Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-κB
- 1 September 2009
- journal article
- Published by Elsevier BV in Nutrition
- Vol. 25 (9), 964-972
- https://doi.org/10.1016/j.nut.2008.12.007
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- TGF-β induces p65 acetylation to enhance bacteria-induced NF-κB activationThe EMBO Journal, 2007
- Multiple biological activities of curcumin: A short reviewLife Sciences, 2006
- EDB fibronectin and angiogenesis – a novel mechanistic pathwayAngiogenesis, 2005
- Curcumin and Turmeric Delay Streptozotocin-Induced Diabetic Cataract in RatsPublished by Association for Research in Vision and Ophthalmology (ARVO) ,2005
- Endothelin‐mediated remodeling in aortas of diabetic ratsDiabetes/Metabolism Research and Reviews, 2004
- Curcumin inhibits UV irradiation‐induced oxidative stress and apoptotic biochemical changes in human epidermoid carcinoma A431 cellsJournal of Cellular Biochemistry, 2003
- Repression of transforming-growth-factor-β-mediated transcription by nuclear factor κBBiochemical Journal, 2000
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Pharmacology ofCurcuma longaPlanta Medica, 1991
- Natural antioxidants. III. Antioxidative components isolated from rhizome of Curcuma longa L.CHEMICAL & PHARMACEUTICAL BULLETIN, 1985